Natco Pharma appoints G Vijay Kiran Kumar as VP- Corporate Quality Assurance (Formulations)

Written By : Ruchika Sharma Published On 2025-10-12T13:30:43+05:30 | Updated On 12 Oct 2025 1:30 PM IST

Hyderabad: Natco Pharma has announced the appointment of G. Vijay Kiran Kumar as Vice President - Corporate Quality Assurance (Formulations) of the Company.

G. Vijay Kiran Kumar is an illustrious Quality assurance professional turned Operational head, over 24 years of profound expertise in the pharmaceutical industry experience in the leading Indian Bulk Drug/API Manufacturing Industries. He has a stellar career marked by adept handling of multifaceted responsibilities encompassing cGMP and GLP standards, regulatory requisites, production operations management, avant-garde technology transfer and executions, quality and audits compliance, fiscal stewardship (budget management), risk mitigation, program management, project management, GAP analysis, and training.

Before joining Natco, Kumar was associated with Dr. Reddy’s Laboratories Limited as Plant Head. He also worked with Aurobindo Pharma, Bharat Biotech, Strides, Hetero, and Cryo-Save.

Read also: Natco Pharma appoints TC Mallikarjuna as Vice President - QC at Kothur Pharma Division

NATCO Pharma Limited, headquartered at Hyderabad, India, develops, manufactures and distributes generic and branded pharmaceuticals, specialty pharmaceuticals, active pharmaceutical ingredients and crop protection products. The Company is a R&D oriented, and a science driven company in the targeted therapies of domestic market and focuses on limited competition molecule in the US. The Company has 9 manufacturing sites and 2 R&D facilities in India. The Company’s different manufacturing facilities are approved by several leading regulatory authorities like US FDA, Brazil ANVISA, Health Canada, WHO and others catering to 50+ global markets.

natco pharmanatco pharma newsappointmentG Vijay Kiran Kumar

Ruchika Sharma

Ruchika Sharma joined Medical Dialogue as an Correspondent for the Business Section in 2019. She covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She has completed her B.Com from Delhi University and then pursued postgraduation in M.Com. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751